Follow
August F. Jernbom
August F. Jernbom
Other namesAugust Falk Jernbom, August Jernbom Falk
KTH Royal Institute of Technology, SciLifeLab
Verified email at scilifelab.se
Title
Cited by
Cited by
Year
SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden
AS Rudberg, S Havervall, A Månberg, A Jernbom Falk, K Aguilera, H Ng, ...
Nature communications 11 (1), 5064, 2020
3442020
Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID‐19
S Havervall, H Ng, A Jernbom Falk, N Greilert‐Norin, A Månberg, ...
Journal of internal medicine 291 (1), 72-80, 2022
642022
SARS-CoV-2 induces a durable and antigen specific humoral immunity after asymptomatic to mild COVID-19 infection
S Havervall, A Jernbom Falk, J Klingström, H Ng, N Greilert-Norin, ...
PLoS One 17 (1), e0262169, 2022
472022
Array-based profiling of proteins and autoantibody repertoires in CSF
E Pin, R Sjöberg, E Andersson, C Hellström, J Olofsson, A Jernbom Falk, ...
Cerebrospinal fluid (CSF) proteomics: methods and protocols, 303-318, 2019
382019
Systematic evaluation of SARS‐CoV‐2 antigens enables a highly specific and sensitive multiplex serological COVID‐19 assay
S Hober, C Hellström, J Olofsson, E Andersson, S Bergström, ...
Clinical & Translational Immunology 10 (7), e1312, 2021
322021
Multiomics profiling of Alzheimer’s disease serum for the identification of autoantibody biomarkers
P San Segundo-Acosta, A Montero-Calle, A Jernbom-Falk, ...
Journal of Proteome Research 20 (11), 5115-5130, 2021
262021
Autoantibody profiles associated with clinical features in psychotic disorders
A Jernbom Falk, C Galletly, D Just, C Toben, BT Baune, SR Clark, D Liu, ...
Translational Psychiatry 11 (1), 474, 2021
192021
SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden. Nat Commun 2020; 11: 5064
AS Rudberg, S Havervall, A Månberg, A Jernbom Falk, K Aguilera, H Ng, ...
13
An evaluation of a FluoroSpot assay as a diagnostic tool to determine SARS-CoV-2 specific T cell responses
SM Mangsbo, S Havervall, I Laurén, R Lindsay, A Jernbom Falk, ...
PLoS One 16 (9), e0258041, 2021
122021
Antibodies to SARS-CoV-2 and risk of past or future sick leave
J Dillner, KM Elfström, J Blomqvist, C Eklund, C Lagheden, ...
Scientific reports 11 (1), 5160, 2021
122021
SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden. Nat Commun. 2020; 11 (1): 5064
AS Rudberg, S Havervall, A Månberg, A Jernbom Falk, K Aguilera, H Ng, ...
Epub 2020/10/10. https://doi. org/10.1038/s41467-020-18848-0 PMID: 33033249, 0
10
High amounts of SARS-CoV-2 precede sickness among asymptomatic health care workers
J Dillner, KM Elfström, J Blomqvist, L Engstrand, M Uhlén, C Eklund, ...
The Journal of Infectious Diseases 224 (1), 14-20, 2021
72021
Systematic evaluation of SARS-CoV-2 antigens enables a highly specific and sensitive multiplex serological COVID-19 assay. Clin Transl Immunology. 2021; 10 (7): e1312
S Hober, C Hellström, J Olofsson, E Andersson, S Bergström, ...
Epub 2021/07/24. https://doi. org/10.1002/cti2. 1312 PMID: 34295471, 0
5
Comparative serum proteomic analysis of a selected protein panel in individuals with schizophrenia and bipolar disorder and the impact of genetic risk burden on serum proteomic …
M Oraki Kohshour, NR Kannaiyan, AJ Falk, S Papiol, U Heilbronner, ...
Translational Psychiatry 12 (1), 471, 2022
42022
Prevalent and persistent new-onset autoantibodies in mild to severe COVID-19
AF Jernbom, L Skoglund, E Pin, R Sjöberg, H Tegel, S Hober, E Rostami, ...
Nature Communications 15 (1), 8941, 2024
22024
On the analysis of antibody repertoires
A Jernbom Falk
KTH Royal Institute of Technology, 2023
2023
BEYOND NEURORECEPTOR AUTOIMMUNITY: PERIPHERAL AUTOANTIBODY PROFILES ARE ASSOCIATED WITH CLINICAL FEATURES IN PSYCHOTIC DISORDERS
A Jernbom Falk, C Galletly, D Just, C Toben, BT Baune, SR Clark, D Liu, ...
Australian and New Zealand journal of psychiatry (Print) 56 (1_SUPPL), 90-91, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–17